RhoVac Management

How experienced are the management team and are they aligned to shareholders interests?

3.8yrs

Average board tenure


CEO

Lars Hedbys (65 yo)

7.83yrs

Tenure

kr191,610

Compensation

Mr. Lars Hedbys, Ph D., serves as Director at Hamlet Pharma AB (publ). He serves as Independent Chairman of the Board of Directors at Scandinavian ChemoTech AB (publ) since 2020.He serves as Director at X...


Board Members

NamePositionTenureCompensationOwnership
Lars Hedbys
Acting CEO & Director7.83yrskr191.61k0.20%
SEK 20.0k
Per Straten
Scientific Advisor & Co-Founderno datano datano data
Lars Hockenstrom
Director2.83yrskr191.61k0.012%
SEK 1.2k
Cristina Glad
Director7.83yrskr160.69k0.058%
SEK 5.6k
Gunnar Gardemyr
Chairman4.83yrskr383.22k0.086%
SEK 8.4k
Georg Holländer
Scientific Advisory Board2.17yrsno datano data
Anne Ridley
Member of Scientific Advisory Board2.75yrsno datano data
Per-Anders Abrahamsson
Scientific advisorno datano datano data
Klaus Brasso
Scientific Advisorno datano datano data

3.8yrs

Average Tenure

65.5yo

Average Age

Experienced Board: RHOVAC's board of directors are considered experienced (3.8 years average tenure).